tiprankstipranks
Trending News
More News >
Akzo Nobel NV (NL:AKZA)
:AKZA

Akzo Nobel NV (AKZA) AI Stock Analysis

Compare
1 Followers

Top Page

NL

Akzo Nobel NV

(LSE:AKZA)

71Outperform
Akzo Nobel NV presents a stable investment opportunity with moderate financial health and decent technical indicators. The company's reliance on debt and stagnant revenue growth are key risks, but the fair valuation and attractive dividend yield provide a balanced outlook. Technical analysis indicates upward momentum, though caution is advised due to potential overbought conditions.

Akzo Nobel NV (AKZA) vs. S&P 500 (SPY)

Akzo Nobel NV Business Overview & Revenue Model

Company DescriptionAkzo Nobel N.V. engages in the production and sale of paints and coatings worldwide. It offers decorative paints, including paints, lacquers, and varnishes; and a range of mixing machines and color concepts for the building and renovation industry, as well as specialty coatings for metal, wood, and other building materials. The company also provides performance coatings that protect and enhance ships, cars, aircraft, yachts, architectural components, consumer goods, and oil and gas facilities. It offers its products primarily under Dulux, International, Sikkens, and Interpon brands. The company was formerly known as Akzo NV and changed its name to Akzo Nobel N.V. in 1994. Akzo Nobel N.V. was founded in 1646 and is headquartered in Amsterdam, the Netherlands.
How the Company Makes MoneyAkzo Nobel NV generates revenue primarily through the sale of its decorative paints and performance coatings. The Decorative Paints segment focuses on products for both consumer and professional markets, offering a variety of indoor and outdoor paints, lacquers, and varnishes. The Performance Coatings segment provides coatings for industrial applications, including automotive, aerospace, and marine industries. Key revenue streams include direct sales to consumers, as well as partnerships and contracts with businesses and industrial clients. The company also invests in innovation and sustainability, which enhances its market position and attracts environmentally conscious customers. Strategic acquisitions and a global distribution network further bolster its earnings by expanding market reach and product offerings.

Akzo Nobel NV Financial Statement Overview

Summary
Overall, Akzo Nobel NV demonstrates stable financial health with moderate profitability and leverage. While operational efficiency is decent, the stagnation in revenue growth and reliance on debt could pose risks if not managed properly. The cash flow reflects stable operations but indicates a need for improved cash generation and growth momentum.
Income Statement
71
Positive
Akzo Nobel NV's income statement shows moderate performance with a gross profit margin of 40.2% and a net profit margin of 4.4% for TTM. There is a slight revenue decline of 0.3% in TTM compared to the previous year, indicating stable but stagnant revenue growth. EBIT and EBITDA margins stand at 8.0% and 11.9% respectively, reflecting decent operational efficiency. However, the company's overall profitability is impacted by the declining revenue trend.
Balance Sheet
68
Positive
The balance sheet of Akzo Nobel NV reveals a debt-to-equity ratio of 1.27, suggesting a moderate leverage level. The return on equity (ROE) is 10.1%, which indicates satisfactory profitability relative to equity. The equity ratio of 31.1% signifies a balanced capital structure but highlights a reliance on debt. While the company maintains a stable asset base, the reliance on debt poses potential financial risk.
Cash Flow
65
Positive
Cash flow analysis shows a stable operating cash flow to net income ratio of 1.56, indicating efficient conversion of income into cash. However, the free cash flow growth rate is low at 7.6% compared to the previous period, and the free cash flow to net income ratio is 0.84, suggesting moderate cash generation relative to net income. The cash flow performance reflects stable operations but lacks significant growth.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
10.68B10.71B10.67B10.85B9.59B8.53B
Gross Profit
4.30B4.34B4.23B3.92B3.85B3.79B
EBIT
852.00M917.00M1.03B708.00M1.12B963.00M
EBITDA
1.27B1.40B1.41B1.05B1.50B1.34B
Net Income Common Stockholders
468.00M542.00M442.00M352.00M829.00M630.00M
Balance SheetCash, Cash Equivalents and Short-Term Investments
1.77B1.47B1.78B1.79B1.21B1.86B
Total Assets
14.85B14.25B14.90B14.74B13.88B13.18B
Total Debt
5.89B5.37B5.56B5.88B3.55B2.89B
Net Debt
4.29B4.07B4.05B4.42B2.40B1.28B
Total Liabilities
9.99B9.43B10.36B10.19B8.24B7.23B
Stockholders Equity
4.62B4.57B4.32B4.33B5.42B5.75B
Cash FlowFree Cash Flow
395.00M367.00M840.00M-29.00M317.00M962.00M
Operating Cash Flow
731.00M673.00M1.12B263.00M605.00M1.22B
Investing Cash Flow
-415.00M-132.00M-144.00M-1.09B-134.00M-427.00M
Financing Cash Flow
368.00M-684.00M-827.00M1.14B-974.00M-353.00M

Akzo Nobel NV Technical Analysis

Technical Analysis Sentiment
Positive
Last Price59.56
Price Trends
50DMA
55.90
Positive
100DMA
56.01
Positive
200DMA
56.20
Positive
Market Momentum
MACD
1.41
Negative
RSI
63.97
Neutral
STOCH
79.48
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NL:AKZA, the sentiment is Positive. The current price of 59.56 is above the 20-day moving average (MA) of 55.63, above the 50-day MA of 55.90, and above the 200-day MA of 56.20, indicating a bullish trend. The MACD of 1.41 indicates Negative momentum. The RSI at 63.97 is Neutral, neither overbought nor oversold. The STOCH value of 79.48 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NL:AKZA.

Akzo Nobel NV Peers Comparison

Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
€10.03B21.4310.15%3.41%0.31%-11.62%
64
Neutral
$4.39B12.065.17%249.63%4.03%-11.04%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NL:AKZA
Akzo Nobel NV
59.56
-3.24
-5.16%
GB:0NX1
Aalberts Industries N.V.
30.97
-14.05
-31.21%
GB:0QVU
IMCD N.V.
124.09
-16.79
-11.92%
GB:0QGH
OCI N.V.
7.64
1.10
16.82%
GB:0RHI
Signify NV
20.48
-3.28
-13.80%
GB:0NO1
TKH Group N.V.
38.64
-1.82
-4.50%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.